FGF23 and Obesity: The observed alterations in FGF-2, FGF-19, FGF-22, and FGF-23 concentrations—particularly their associations with hypertension, obesity, nephropathy, and joint degeneration—support their role not only in the pathogenesis but also in the clinical stratification of diabetic complications.